CLRB
CLRB
NASDAQ · Biotechnology

Cellectar Biosciences Inc

$2.58
+0.04 (+1.57%)
Analyst Consensus
Buy
10
Analysts
Moderate
Coverage
Buy 7 70%
Hold 3 30%
Sell 0 0%
Price Target
Analyst Price Target +1,500.0% upside
Low Target $32.58
Average Target $41.28
High Target $58.47
Current Price $2.58
Current
$2.58
Target
$41.28
$32.58 $41.28 avg $58.47
Scenario Analysis
Bear Case
$32.58
1,162.8%
Low target
Base Case
$41.28
+1,500.0%
Avg target
Bull Case
$58.47
+2,166.3%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$20.59
-87.5% from high
52-Week Low
$2.45
+5.3% from low
Target vs 52W High
$41.28
+100.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.9%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +157.7%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.5%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.0%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.5%